CGI
IDXX icon

Comgest Global Investors’s Idexx Laboratories IDXX Stock Holding History

Comgest Global Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138M Buy
262,562
+42,208
+19% +$23.7M 3.04% 12
2026
Q1 		$124M Buy
220,354
+13,277
+6% +$8.51M 2.7% 13
2025
Q4 		$140M Sell
207,077
-37,145
-15% -$25.3M 2.5% 14
2025
Q3 		$156M Buy
244,222
+113
+0% +$68.6K 2.76% 13
2025
Q2 		$131M Sell
244,109
-1,192
-0.5% -$570K 2.23% 18
2025
Q1 		$103M Buy
245,301
+53,790
+28% +$23.4M 1.84% 18
2024
Q4 		$79.2M Buy
191,511
+145,203
+314% +$63.7M 1.3% 19
2024
Q3 		$23.4M Buy
46,308
+12,353
+36% +$6M 0.34% 34
2024
Q2 		$16.5M Buy
33,955
+7,130
+27% +$3.58M 0.23% 38
2024
Q1 		$14.5M Buy
26,825
+1,805
+7% +$986K 0.2% 40
2023
Q4 		$13.9M Buy
25,020
+3,065
+14% +$1.44M 0.21% 40
2023
Q3 		$9.6M Buy
21,955
+4,589
+26% +$2.29M 0.16% 43
2023
Q2 		$8.72M Sell
17,366
-1,257
-7% -$602K 0.15% 43
2023
Q1 		$9.31M Sell
18,623
-455
-2% -$218K 0.17% 42
2022
Q4 		$7.78M Buy
19,078
+1,611
+9% +$625K 0.17% 43
2022
Q3 		$5.69M Buy
17,467
+2,823
+19% +$1.04M 0.13% 46
2022
Q2 		$5.14M Buy
14,644
+3,531
+32% +$1.44M 0.1% 47
2022
Q1 		$6.08M Buy
11,113
+7,611
+217% +$4M 0.1% 47
2021
Q4 		$2.31M Buy
+3,502
New +$2.2M 0.03% 51

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Comgest Global Investors's IDXX Position: Q2 2026 in Review

Comgest Global Investors increased its Idexx Laboratories (IDXX) stake by 19% in Q2 2026, buying an estimated $23.7M and bringing the position to 262,562 shares worth $138M. The position accounts for 3.04% of the portfolio, ranked #12.

Comgest Global Investors first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $156M in Q3 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Comgest Global Investors held 262,562 shares of Idexx Laboratories worth $138M as of Q2 2026.
  • Comgest Global Investors bought 42,208 Idexx Laboratories shares in Q2 2026, an estimated $23.7M.
  • Idexx Laboratories made up 3.04% of Comgest Global Investors's portfolio in Q2 2026, its #12 holding.
  • Comgest Global Investors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Comgest Global Investors's Idexx Laboratories position peaked at $156M in Q3 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Comgest Global Investors's 13F filing for Q2 2026, filed 24 Jul 2026.